Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for cystinuria type B.
3 publications have been identified in PubMed for cystinuria type B. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Gene Therapy / Novel Therapeutics (33%).
Iuliano I (2025). [PMID: 40562017](https://pubmed.ncbi.nlm.nih.gov/40562017/). *Kidney Blood Press Res*. [Review / Meta-Analysis]
Suh SH (2025). [PMID: 40630605](https://pubmed.ncbi.nlm.nih.gov/40630605/). *Electrolyte Blood Press*. [Case Report / Case Series]
Hu L (2024). [PMID: 39015267](https://pubmed.ncbi.nlm.nih.gov/39015267/). *ACS Med Chem Lett*. [Gene Therapy / Novel Therapeutics]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning cystinuria type B
Updated Aug 18, 2026
Researchers have developed a novel Slc7a9(G105R) mutant mouse model that reveals new biomarkers for cystinuria. This discovery could enhance understanding and diagnosis of the disease.
A narrative review on cystinuria discusses current diagnostic methods, medical and surgical management strategies, and highlights emerging therapies. This comprehensive overview aims to enhance understanding and treatment approaches for this rare condition.